{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T11:22:42Z","timestamp":1767180162840,"version":"build-2238731810"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T00:00:00Z","timestamp":1524009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BPD\/76225\/2011"],"award-info":[{"award-number":["SFRH\/BPD\/76225\/2011"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/89140\/2012"],"award-info":[{"award-number":["SFRH\/BD\/89140\/2012"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["VIH\/SAU\/0029\/2011"],"award-info":[{"award-number":["VIH\/SAU\/0029\/2011"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0195744","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T15:11:00Z","timestamp":1524064260000},"page":"e0195744","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2022-8921","authenticated-orcid":true,"given":"In\u00eas","family":"B\u00e1rtolo","sequence":"first","affiliation":[]},{"given":"Ana Rita","family":"Diniz","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"Borrego","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o Pedro","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Maria Ros\u00e1rio","family":"Bronze","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4098-5433","authenticated-orcid":true,"given":"Helena","family":"Barroso","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1667-7871","authenticated-orcid":true,"given":"Rui","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Cardoso","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o F.","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"Rafael Ce\u00f1a","family":"Diaz","sequence":"additional","affiliation":[]},{"given":"Pilar Garcia","family":"Broncano","sequence":"additional","affiliation":[]},{"given":"Maria Angel","family":"Mu\u00f1oz-Fern\u00e1ndez","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0176-5585","authenticated-orcid":true,"given":"Nuno","family":"Taveira","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2018,4,18]]},"reference":[{"key":"ref1","article-title":"AIDS by the numbers","year":"2016"},{"key":"ref2","article-title":"HIV Fact sheet November 2016","year":"2016"},{"key":"ref3","first-page":"1","article-title":"Sexual communication self-efficacy, hegemonic masculine norms and condom use among heterosexual couples in South Africa","volume":"7","author":"A Leddy","year":"2015","journal-title":"AIDS Care"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/COH.0000000000000170","article-title":"The current status of the use of oral medication to prevent HIV transmission","volume":"10","author":"KH Mayer","year":"2015","journal-title":"Curr Opin HIV AIDS"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1089\/aid.2015.0095","article-title":"Sub-Epidemics Explain Localized High Prevalence of Reduced Susceptibility to Rilpivirine in Treatment-Naive HIV-1-Infected Patients: Subtype and Geographic Compartmentalization of Baseline Resistance Mutations","volume":"32","author":"K Theys","year":"2016","journal-title":"AIDS research and human retroviruses"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/cid\/civ324","article-title":"Effects of Emtricitabine\/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial","volume":"61","author":"K Mulligan","year":"2015","journal-title":"Clinical infectious diseases"},{"key":"ref7","unstructured":"Gandhi M, Glidden D, Liu AY, Horng H, Amico KR, Mulligan K, et al. Higher cumulative TFV\/FTC levels in PrEP associated with decline in renal function. Conference on Retroviruses and Opportunistic Infections; Boston, MA2016."},{"key":"ref8","unstructured":"Liu AY, Vittinghoff E, Anderson PL, Cohen S, Doblecki-Lewis S, Bacon O, et al. Changes in renal function associated with TDF\/FTC PrEP use in the US Demo Project. Conference on Retroviruses and Opportunistic Infections; Boston, MA2016."},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.2174\/1568026615666150901113939","article-title":"Current Concepts for the IND-Directed Development of Microbicide Products to Prevent the Sexual Transmission of HIV","volume":"16","author":"TK Buckheit","year":"2016","journal-title":"Curr Top Med Chem"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/157016212799304698","article-title":"An algorithm for the preclinical development of anti-HIV topical microbicides","volume":"10","author":"RW Buckheit Jr","year":"2012","journal-title":"Curr HIV Res"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/QCO.0b013e328334de6d","article-title":"Microbicides and HIV prevention: lessons from the past, looking to the future","volume":"23","author":"GC Morris","year":"2010","journal-title":"Curr Opin Infect Dis"},{"key":"ref12","first-page":"295","article-title":"Nutan. Clinical use of vaginal or rectally applied microbicides in patients suffering from HIV\/AIDS","volume":"5","author":"SK Gupta","year":"2013","journal-title":"HIV AIDS (Auckl)"},{"issue":"9749","key":"ref13","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(10)61086-0","article-title":"PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial","volume":"376","author":"S McCormack","year":"2010","journal-title":"Lancet"},{"issue":"9654","key":"ref14","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/S0140-6736(08)61842-5","article-title":"Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial","volume":"372","author":"S Skoler-Karpoff","year":"2008","journal-title":"Lancet"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1056\/NEJMoa0707957","article-title":"Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission","volume":"359","author":"L Van Damme","year":"2008","journal-title":"N Engl J Med"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa1402269","article-title":"Tenofovir-based preexposure prophylaxis for HIV infection among African women","volume":"372","author":"JM Marrazzo","year":"2015","journal-title":"N Engl J Med"},{"key":"ref17","first-page":"2015","article-title":"FACTS 001 Phase III Trial of Pericoital Tenofovir 1% Gel for HIV Prevention in Women","author":"H Rees","year":"2015","journal-title":"CROI"},{"key":"ref18","article-title":"Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women","author":"JM Baeten","year":"2016","journal-title":"The New England journal of medicine"},{"key":"ref19","year":"2013"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(15)00536-8","article-title":"Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study","volume":"16","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"e20209","DOI":"10.1371\/journal.pone.0020209","article-title":"A Topical Microbicide Gel Formulation of CCR5 Antagonist Maraviroc Prevents HIV-1 Vaginal Transmission in Humanized RAG-hu Mice","volume":"6","author":"CP Neff","year":"2011","journal-title":"PLoS One"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/QAD.0b013e32835edc1d","article-title":"An ancestral HIV-2\/simian immunodeficiency virus peptide with potent HIV-1 and HIV-2 fusion inhibitor activity","volume":"27","author":"P Borrego","year":"2013","journal-title":"AIDS"},{"issue":"33","key":"ref23","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.2174\/138161210794079218","article-title":"Inhibition of HIV-1 by fusion inhibitors","volume":"16","author":"D Eggink","year":"2010","journal-title":"Curr Pharm Des"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3851\/IMP1996","article-title":"Baseline susceptibility of primary HIV-2 to entry inhibitors","volume":"17","author":"P Borrego","year":"2012","journal-title":"Antivir Ther"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1128\/JVI.01743-08","article-title":"Human immunodeficiency virus type 2 (HIV-2)\/HIV-1 envelope chimeras detect high titers of broadly reactive HIV-1 V3-specific antibodies in human plasma","volume":"83","author":"KL Davis","year":"2009","journal-title":"J Virol"},{"key":"ref26","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"LJ Reed","year":"1938","journal-title":"The American Journal of Hygiene"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0010-7824(99)00010-4","article-title":"A vaginal fluid simulant","volume":"59","author":"DH Owen","year":"1999","journal-title":"Contraception"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0022-1759(97)00043-4","article-title":"Assessment of the Alamar Blue assay for cellular growth and viability in vitro","volume":"204","author":"GR Nakayama","year":"1997","journal-title":"J Immunol Methods"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/01443619868325","article-title":"A study of the prevalence of hydrogen peroxide generating Lactobacilli in bacterial vaginosis: the determination of H2O2 concentrations generated, in vitro, by isolated strains and the levels found in vaginal secretions of women with and without infection","volume":"18","author":"S Al-Mushrif","year":"1998","journal-title":"J Obstet Gynaecol"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/10520290701375278","article-title":"Indigogenic substrates for detection and localization of enzymes","volume":"82","author":"JA Kiernan","year":"2007","journal-title":"Biotech Histochem"},{"key":"ref31","year":"2010"},{"key":"ref32","unstructured":"CLSI. Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved Standard, 12th ed.: Clinical and Laboratory Standards Institute2015. Report No.: M02-A12."},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jpha.2015.11.005","article-title":"Methods for in vitro evaluating antimicrobial activity","volume":"6","author":"M Balouiri","year":"2016","journal-title":"A review Journal of Pharmaceutical Analysis"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jconrel.2012.04.050","article-title":"Carbosilane dendrimer nanotechnology outlines of the broad HIV blocker profile","volume":"161","author":"L Chonco","year":"2012","journal-title":"J Control Release"},{"key":"ref35","article-title":"Vaginal Microbicides: Development for the Prevention of HIV Infection","year":"2014"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4615-0549-5_1","article-title":"Preformulation studies as an essential guide to formulation development and manufacture of protein pharmaceuticals","volume":"14","author":"DB Volkin","year":"2002","journal-title":"Pharm Biotechnol"},{"issue":"4","key":"ref37","first-page":"111","article-title":"[Role of pH as a regulator of vaginal physiological environment]","volume":"52","author":"GB Melis","year":"2000","journal-title":"Minerva Ginecol"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2164\/jandrol.04104","article-title":"A review of the physical and chemical properties of human semen and the formulation of a semen simulant","volume":"26","author":"DH Owen","year":"2005","journal-title":"J Androl"},{"key":"ref39","first-page":"337","article-title":"Production of antimicrobial substances by lactic acid bacteria I: determination of hydrogen peroxide","volume":"268","author":"MS Tomas","year":"2004","journal-title":"Methods Mol Biol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-6405-8-27","article-title":"Preformulation and stability in biological fluids of the retrocyclin RC-101, a potential anti-HIV topical microbicide","volume":"8","author":"AB Sassi","year":"2011","journal-title":"AIDS Res Ther"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/MAJ.0b013e31823ea228","article-title":"The microbiota of the vagina and its influence on women's health and disease","volume":"343","author":"DH Martin","year":"2012","journal-title":"Am J Med Sci"},{"issue":"5","key":"ref42","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1128\/AAC.01623-10","article-title":"In vitro activity of nifuratel on vaginal bacteria: could it be a good candidate for the treatment of bacterial vaginosis?","volume":"55","author":"G Togni","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"ref43","first-page":"S17","article-title":"The vaginal microbial ecosystem and resistance to HIV","volume":"14","author":"SL Hillier","year":"1998","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref44","article-title":"A helical short-peptide fusion Inhibitor with highly potent activities against HIV-1, HIV-2 and Simian Immunodeficiency Virus","author":"S Xiong","year":"2016","journal-title":"J Virol"},{"issue":"10","key":"ref45","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1089\/aid.2005.21.845","article-title":"In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials","volume":"21","author":"D Tien","year":"2005","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.contraception.2006.09.003","article-title":"Fourteen-day safety and acceptability study of the universal placebo gel","volume":"75","author":"JL Schwartz","year":"2007","journal-title":"Contraception"},{"issue":"9","key":"ref47","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1086\/522606","article-title":"Seminal plasma reduces the effectiveness of topical polyanionic microbicides","volume":"196","author":"S Patel","year":"2007","journal-title":"J Infect Dis"},{"issue":"9","key":"ref48","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1086\/513279","article-title":"A comprehensive murine model to evaluate topical vaginal microbicides: mucosal inflammation and susceptibility to genital herpes as surrogate markers of safety","volume":"195","author":"BT Galen","year":"2007","journal-title":"J Infect Dis"},{"issue":"11","key":"ref49","doi-asserted-by":"crossref","first-page":"e27675","DOI":"10.1371\/journal.pone.0027675","article-title":"Bridging the gap between preclinical and clinical microbicide trials: blind evaluation of candidate gels in murine models of efficacy and safety","volume":"6","author":"TJ Segarra","year":"2011","journal-title":"PLoS One"},{"issue":"suppl 1","key":"ref50","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1093\/infdis\/jiw184","article-title":"The Vaginal Microbiome: Current Understanding and Future Directions","volume":"214","author":"DH Martin","year":"2016","journal-title":"J Infect Dis"},{"issue":"4\u20137","key":"ref51","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1081\/NCN-100002540","article-title":"Kinetic studies of the degradation of oxycarbonyloxymethyl prodrug of Adefovir and Tenofovir in solution","volume":"20","author":"R Oliyai","year":"2001","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.2042-7158.2004.tb02573.x","article-title":"Preformulation stability of Spantide II, a promising topical anti-inflammatory agent for the treatment of psoriasis and contact dermatitis","volume":"56","author":"L Kikwai","year":"2004","journal-title":"J Pharm Pharmacol"},{"issue":"10","key":"ref53","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1473-3099(02)00396-1","article-title":"Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomised controlled trials including more than 5000 women","volume":"2","author":"D Wilkinson","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"ref54","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/13625180500280753","article-title":"Microbicidal spermicide or spermicidal microbicide?","volume":"10","author":"G Gupta","year":"2005","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1743-422X-9-33","article-title":"Application and removal of polyanionic microbicide compounds enhances subsequent infection by HIV-1","volume":"9","author":"V Pirrone","year":"2012","journal-title":"Virol J"},{"issue":"4","key":"ref56","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1086\/600867","article-title":"Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety","volume":"200","author":"PM Mesquita","year":"2009","journal-title":"J Infect Dis"},{"issue":"5","key":"ref57","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00007435-200205000-00007","article-title":"Microflora changes with the use of a vaginal microbicide","volume":"29","author":"JG Clarke","year":"2002","journal-title":"Sex Transm Dis"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fphys.2015.00081","article-title":"Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health","volume":"6","author":"MI Petrova","year":"2015","journal-title":"Front Physiol"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0197015","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T00:00:00Z","timestamp":1525219200000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0195744","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T12:08:56Z","timestamp":1589026136000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0195744"}},"subtitle":[],"editor":[{"given":"Philippe A.","family":"Gallay","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2018,4,18]]},"references-count":58,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0195744","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,18]]}}}